GGrantIndex
Sort

35,931 grants matching parkinsons

Collaborative GWAS of Dementia, AD and related MRI and Cognitive Endophenotypes

$536,308
Sudha Seshadri · Boston University Medical Campus · R01 · FY2011 · AG

GENE-METAL INTERACTIONS AND PARKINSON'S DISEASE

$536,296
Brigham And Women'S Hospital · R01 · FY2002 · ES

Investigation of Pallidal Neurons in Motor Inhibition

$536,293
Savio Chan · Northwestern University At Chicago · R56 · FY2022 · NS

Development of STEP substrates and probes as novel tools and therapeutics for Alzheimer's disease

$536,250
Lutz Tautz · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2020 · AG

Attention and Executive Functioning in Aging and Parkisonism

$536,204
Jay S Schneider · Thomas Jefferson University · R01 · FY2010 · NS

Miniature Passive Device for Locating Lost Dentures in Care Facilities

$536,174
Suneel Ismail Sheikh · Aster Labs, Inc. · R44 · FY2019 · DE

INVESTIGATIONS OF DEMENTIA IN PARKINSON DISEASE

$536,156
Joel Synes Perlmutter · Washington University · R01 · FY2015 · NS

Single molecule studies of SNARE-induced vesicle fusion

$536,061
Axel T. Brunger · Stanford University · R37 · FY2017 · MH

Single molecule studies of SNARE-induced vesicle fusion

$536,061
Axel T. Brunger · Stanford University · R37 · FY2018 · MH

Single molecule studies of SNARE-induced vesicle fusion

$536,061
Axel T. Brunger · Stanford University · R37 · FY2020 · MH

Single molecule studies of SNARE-induced vesicle fusion

$536,061
Axel T. Brunger · Stanford University · R37 · FY2019 · MH

In vivo and in vitro systems to validate geronic proteins and their mechanisms of action

$536,036
Tamas L Horvath · Yale University · R01 · FY2017 · AG

Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease

$536,020
Kiran Solingapuram Sai · Wake Forest University Health Sciences · R01 · FY2021 · AG

Neuroprotection by Mitochondria-targeted Antioxidants

$536,010
Balaraman Kalyanaraman · Medical College Of Wisconsin · R01 · FY2011 · NS

Spatiotemporal optimization of deep brain stimulation for Parkinson's Disease

$535,934
Matthew Douglas Johnson · University Of Minnesota · R01 · FY2017 · NS

NeuroMAP System for Clinical Research

$535,902
Gianluca De Luca · Altec, Inc. · R44 · FY2020 · NS

Mechanisms of LRRK2 Mediated Neurotoxicity

$535,841
Andrew B West · Duke University · R01 · FY2023 · NS

Mechanisms of LRRK2 Mediated Neurotoxicity

$535,841
Andrew B West · Duke University · R01 · FY2025 · NS

Mechanisms of LRRK2 Mediated Neurotoxicity

$535,841
Andrew B West · Duke University · R01 · FY2022 · NS

Mechanisms of LRRK2 Mediated Neurotoxicity

$535,841
Andrew B West · Duke University · R01 · FY2021 · NS

Tissue Engineered Rostral Migratory Stream for Directed Neuronal Replacement

$535,788
Daniel Kacy Cullen · University Of Pennsylvania · R01 · FY2024 · NS

Designed Vehicles for Blood Brain Barrier Traversal

$535,766
David Baker · University Of Washington · R01 · FY2019 · AG

Gene therapy targeting striatal dysfunction for Parkinson’s disease

$535,690
Stella M Papa · Emory University · R01 · FY2024 · NS

Neurophysiological mechanisms underlying parkinsonian motor signs

$535,642
Jerrold L Vitek · University Of Minnesota · R01 · FY2020 · NS

SUMO family Ubiquitin-like Modifiers In Higher Eukaryotes

$535,580
Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD